B
Bolt Biotherapeutics, Inc. (BOLT)
NCM – Real Time Price. Currency in USD
4.28
+0.05 (1.07%)
At close: Jun 26, 2026, 4:00 PM EDT
4.37
+0.09 (2.22%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
4.28
+0.05 (1.07%)
At close: Jun 26, 2026, 4:00 PM EDT
4.37
+0.09 (2.22%)
After-hours: Jun 26, 2026, 4:10 PM EDT
No Data
There are no news for this stock.
Total debt $22.3M significantly exceeds cash reserves ($11.8M), raising financial stability concerns
Total current assets $25.8M exceed Total current liabilities $7.3M, highlighting excellent liquidity
Debt-to-equity ratio (1.1) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.51 | 6.05 | 10 | |
| Quick ratio | 3.51 | 5.63 | 10 | |
| Debt to Equity | 1.13 | 0.30 | 6.0 | |
| Debt to Assets | 0.46 | 1.04 | 5.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 6.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 6M | 8M | 8M | 8M | 6M |
| Gross Profit | 838K | 6M | 6M | 6M | 5M |
| Operating Income | -90M | -76M | -68M | -35M | -30M |
| Net Income | -88M | -69M | -63M | -33M | -30M |
| EBITDA | -85M | -74M | -66M | -33M | -29M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -72.22 | 24.07 | 5.5 |
| Next quarter | -76.95 | 13.98 | 4.5 |
| Current year | -85.3 | 11.06 | 4.0 |
| Next year | 106.22 | -25.53 | 5.5 |
| Weighted average score | 4.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -98.95 | -9.23 | -12.23 | 27.01 | 3.3 |
| Y/Y | -97.86 | 34.38 | 25.69 | 50.41 | 7.8 |
| 3y average | 11.73 | 25.79 | 26.07 | 19.36 | 9.0 |
| 5y average | 167.07 | 5.13 | 24.69 | 1.71 | 7.0 |
| Weighted average score | 6.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |